SAMUEL WAXMAN CANCER RESEARCH FOUNDATION (EIN 133020943) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1980

Legal Domicile

Phone

2128674502

Tax Period

2024-07-01 to 2025-06-30

SAMUEL WAXMAN CANCER RESEARCH FOUNDATION, founded in 1980, is a community nonprofit that reported $2.2M in total revenue in fiscal year 2024. Revenue fell 23% from the prior year — a significant decline worth monitoring. Expenses of $2.8M exceeded revenue, resulting in a 27% operating deficit.

Mission

THE SAMUEL WAXMAN CANCER RESEARCH FOUNDATION (THE "FOUNDATION") FUNDS INNOVATIVE RESEARCH TO BRING FASTER CURES TO PATIENTS. (CONTINUED ON SCHEDULE O)

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $2,445,014

Program Service Revenue $0

Investment Income $15,467

Other Revenue $-250,133

TOTAL REVENUE $2,210,348

Expense Breakdown

Grants Paid $617,500

Salaries & Benefits $1,564,566

Fundraising Expenses $692,015

Program Expenses $1,662,780

Other Expenses $521,209

TOTAL EXPENSES $2,806,670

Year-over-Year Comparison

	2024	2023	Change
Revenue	$2,210,348	$2,861,160	-0.2%
Expenses	$2,806,670	$3,737,329	-0.2%
Net Income	$-596,322	$-876,169	-0.3%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$438,210

Total Directors

$250,000

Key Employees

$431,448

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DENA K WEINER	VICE-PRESIDENT	2.0	Officer Director	$0	$0	$0
GERARD J JOYCE	SECRETARY	2.0	Officer Director	$0	$0	$0
MICHAEL NIERENBERG	CHAIRMAN	2.0	Officer Director	$0	$0	$0
NICK SANTORO	TREASURER (as of 07/01/2024)	2.0	Officer Director	$0	$0	$0
SAMUEL WAXMAN MD	DIRECTOR-CEO	20.0	Officer Director	$250,000	$0	$250,000
SPENCER WAXMAN	PRESIDENT	2.0	Officer Director	$0	$0	$0
ARI ZAGDANSKI	DIRECTOR	1.0	Director	$0	$0	$0
BARON SILVERSTEIN	DIRECTOR	1.0	Director	$0	$0	$0
CHRISITNE ARLOTTA	DIRECTOR	1.0	Director	$0	$0	$0
DENNIS A HERMAN	DIRECTOR	1.0	Director	$0	$0	$0
ETHAN DMITROVSKY MD	DIRECTOR	1.0	Director	$0	$0	$0
FREDRICK W BARNEY	DIRECTOR	1.0	Director	$0	$0	$0
GARY JACOB	DIRECTOR	1.0	Director	$0	$0	$0
GARY NOLAN	DIRECTOR	1.0	Director	$0	$0	$0
HOWAD SHLAFMITZ	DIRECTOR	1.0	Director	$0	$0	$0
JAMES FRANKEL	DIRECTOR	1.0	Director	$0	$0	$0
JAMES A INGRAM	DIRECTOR (THRU 02/01/2025)	1.0	Director	$0	$0	$0
JOSEPH STEFFA	DIRECTOR	1.0	Director	$0	$0	$0
KENNETH FISHEL	DIRECTOR (THRU 05/01/2025)	1.0	Director	$0	$0	$0
LEWIS A RUBIN	DIRECTOR	1.0	Director	$0	$0	$0
LINDA HERMAN	DIRECTOR	1.0	Director	$0	$0	$0
MARC TAUB	DIRECTOR	1.0	Director	$0	$0	$0
PEEYUSH MISRA	DIRECTOR	1.0	Director	$0	$0	$0
RIVA ARIELLA RITVO-SLIFKA	DIRECTOR	1.0	Director	$0	$0	$0
SCOTT WAXMAN	DIRECTOR	1.0	Director	$0	$0	$0
SUSEAN PERNICK	DIRECTOR (AS OF 03/01/2025)	1.0	Director	$0	$0	$0
W DAVID HINKELMAN	DIRECTOR	1.0	Director	$0	$0	$0
GREGORY FABIJANCZUK	CFO/DIRECTOR OF FINANCE (thru 04/30/2025)	40.0	Officer	$145,613	$42,597	$188,210
WILLIAM T SULLIVAN	EXECUTIVE DIRECTOR	50.0	Key Emp	$342,514	$88,934	$431,448
KAREN KIRK	DIRECTOR OF SPECIAL EVENTS	40.0	Highest	$121,650	$72,628	$194,278
Suzanna C Houston	Director of Special Projects	40.0	Highest	$130,750	$30,999	$161,749
WYLIE TENE	DIRECTOR OF MARKETING & COMMUNICATION	40.0	Highest	$140,472	$31,981	$172,453

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$2,210,348	$2,806,670	$4,595,379	$-596,322
2024	$2,861,160	$3,737,329	$5,376,278	$-876,169
2023	$4,008,774	$4,004,625	$6,175,563	$4,149
2022	$4,706,095	$2,897,746	$6,125,031	$1,808,349
2021	$2,510,809	$3,593,053	$4,834,675	$-1,082,244
2020	$5,207,449	$3,385,729	$5,139,332	$1,821,720
2019	$4,078,871	$2,935,725	$3,328,184	$1,143,146
2018	$3,647,263	$2,779,634	$2,187,127	$867,629

SAMUEL WAXMAN CANCER RESEARCH FOUNDATION